HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 460 | 557 | 82.6% | |
| HF 4 | 2012 | 494 | 612 | 80.7% | |
| HF 4 | 2013 | 532 | 623 | 85.4% | |
| HF004 | 2014 | 389 | 435 | 89.4% | |
| HF004 | 2015 | 417 | 488 | 85.5% | |
| HF004 | 2016 | 456 | 507 | 89.9% | |
| HF004 | 2017 | 500 | 551 | 90.7% | |
| HF004 | 2018 | 524 | 586 | 89.4% | |
| HF004 | 2019 | 555 | 624 | 88.9% | |
| HF004 | 2020 | 581 | 661 | 87.9% | |
| HF006 | 2021 | 662 | 749 | 88.4% | |
| HF006 | 2022 | 701 | 752 | 93.2% | |
| HF006 | 2023 | 946 | 985 | 96.0% |
